Scorpius Holdings, Inc. (SCPX) Research

Operating as an integrated contract development and manufacturing organization (CDMO), Scorpius Holdings Inc. primarily conducts its business through its subsidiary, Scorpius BioManufacturing. The company offers a comprehensive array of services to pharmaceutical and biotechnology enterprises, spanning analytical testing, downstream process development, formulation optimization, and clinical biomanufacturing. Additionally, Scorpius Holdings supports clients with pre-clinical and product development, provides analytical assistance for Chemistry, Manufacturing, and Control (CMC), and performs various bioassays. Established in Morrisville, North Carolina, and incorporated in 2008, the company adopted its current name in February 2024, having previously been known as NightHawk Biosciences, Inc.

Market snapshot

Symbol
SCPX
Price
$0.00
Day change
0.00%
Market cap
$13.6K
P/E ratio
-0.00x
52-week range
0.0001-0.15
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Ampio Pharmaceuticals, Inc. (AMPE)
  • Bioasis Technologies Inc. (BIOAF)
  • Banyan Corp. (BNYN)
  • Easy Technologies Inc. (EMYSF)
  • GB Sciences, Inc. (GBLX)
  • GlobeStar Therapeutics Corporation (GSTC)
  • IR Biosciences Holdings Inc. (IRBS)
  • Neptune Wellness Solutions Inc. (NEPTF)

Recent insider activity

  • Thuan Tan Sze — trade (0 shares) on 2025-03-03
  • Wolf Jeffrey Alan — A-Award (2500000 shares) on 2024-05-16
  • Wolf Jeffrey Alan — A-Award (2500000 shares) on 2024-05-16

Open Scorpius Holdings, Inc. (SCPX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.